fbpx

All posts by David Emerson

Sonja’s Story- Non-Hodgkin’s Follicular Lymphoma Diagnosis and Survival

I’ll never forget those words, Sonja you have cancer. Non-Hodgkin’s Follicular Lymphoma. And I was already in stage 4. HOW…? WHY…? BUT THEY SAID… OH MY GOD!!! Sonja Braddock was diagnosed

Continue reading

Multiple Myeloma Therapy- Dichloroacetate (DCA)

“The findings of this study shed a new light with respect to some of the novel mechanisms underlying the antitumor action of Dichloroacetate (DCA) and thus may have immense clinical applications.” “It

Continue reading

Ask A Multiple Myeloma Survivor

Hi, my name is David Emerson, and I have been a Multiple Myeloma survivor since 1994. To learn the details of my story, please click here. I believe that talking to a Multiple Myeloma survivor about your

Continue reading

Multiple Myeloma Diet, Supplementation- A How-To Guide

Many studies confirm that a majority of patients undergoing cancer therapy use non-conventional therapies such as the supplements discussed below: Experience and years of research have taught me that multiple

Continue reading

Multiple Myeloma Diagnostics- FISH, SPEP, CBC, FLC’s and Imaging

If you have multiple myeloma your plasma cells produce unhealthy antibodies called monoclonal proteins (M proteins). The accumulation of M proteins in your body can damage organs like your kidneys and

Continue reading

Curcumin, Doxorubicin Combo in Relapsed/Refractory Multiple Myeloma

Conclusion: PAd is an active salvage therapy with manageable toxicity in patients with relapsed/refractory multiple myeloma. The good news is that there is a long and growing list of conventional, FDA

Continue reading

Multiple Myeloma Diagnosis- Can’t Trust Conventional Cancer Research

You were told that a multiple myeloma diagnosis meant that you could live 5-7 years. Consider thinking outside the conventional therapy box… I received my multiple myeloma diagnosis in early 1994.

Continue reading

Multiple Myeloma Chemotherapy – Antioxidants Enhance Action

Much debate has focused on whether antioxidants interfere with the efficacy of cancer chemotherapy. The objective of this study is to systematically review the randomized, controlled clinical trial evidence

Continue reading

DCA enhances Velcade in Multiple Myeloma

Dichloracetate (DCA) enhances the efficacy of Velcade, a standard-of-care Multiple Myeloma Therapy Multiple Myeloma (MM) is considered incurable by conventional oncology. In other words, if an MM patient

Continue reading

White glow? Pink eye? Red eye? Consider Retinoblastoma-

“The longer that retinoblastoma can grow before they’re diagnosed and treated, the more invasive they become” A friend’s daughter was diagnosed with retinoblastoma as an infant.

Continue reading
1 2 3 29